Title of the cohort
Cohort – Suleyman Demirel University
Acronym for cohort
Name of Principal Investigator
| Title | Prof |
| First name | Serpil |
| Last name | Demerici |
Address of institution where award is held
| Institution | Suleyman Demirel University |
| Street Address | |
| City | |
| Postcode |
Country
Turkey
Website
N/A
Contact email
Funding source
1. The cohort includes, or expects to include, incidence of the following conditions
- Alzheimer’s disease and other dementias
When studies on the above condition(s) are expected to become possible
2a. Stated aim of the cohort
N/A
2b. Features distinguishing this cohort from other population cohorts
3a. i) Number of publications that involve use of cohort to date
0
3a. ii) Up to three examples of studies to date (PI, Institution, Title of Study)
3b. Publication list/link to where data or publications are accessible (if available)
3c. Information (i.e. research findings) expected to be gained from the population cohort
4a. Study criteria: age range of participants at recruitment
| Age in years from: | 00 |
| To (‘until death’ if applicable): |
Age in years from: 40 To ('until death' if applicable): until death
N/A
4c. Study criteria: exclusion criteria
N/A
5. Size of the cohort (i.e. number of participants enrolled)
1,000 – 5,000 participants
6a. Measures used to characterise participants
N/A
6b. Additional measures for participants with a clinical disorder
N/A
6c. Are there defined primary and secondary endpoints (e.g. defined health parameters)
No
7. Study design
- Other (please specify)
- N/A
8. Cases matched by
- Other health assessment (specify) / N/A
- N/A
9a. Does the study include a specialised subset of control participants
No
9b. If yes, description of specialised subset of control participants
10a. i) Data collection start date
14-05-2011
10a. ii) Data collection end date
14-05-2011
10a iii) Data collection for this study is
- At the planning stage
10b. Plans to continue the cohort study beyond the current projected end date
- No
11. Data collected
12. System in place to enable re-contact with patients for future studies
13a. Format and availability of data stored in a database
Language used:
13b. Format and availability of data held as individual records
Language used:
14a. Are data available to other groups
Yes
14b. Access policy/mechanisms for access if data are available to other groups
15. Data sharing policy specified as a condition of use
No policy exists
16a. Are tissues/samples/DNA available to other groups
No
16b. i) Description of available tissues/samples/DNA
16b. ii) Form available tissues/samples/DNA are supplied in
16b. iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data
17. Is information on biological characteristics available to other groups
- No